Management of Glioblastoma Multiforme in Elderly Patients: A Review of the Literature.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28465276.
- Also identified by DOI 10.1016/j.wneu.2017.04.153.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults, occurs most commonly in individuals older than 65 years of age, and is universally fatal. Increasing age compounds the poor prognosis of GBM, as elderly patients have markedly worse outcomes than younger patients. However, many of the studies previously investigating optimal treatment regimens exclude patients older than the age of 65 years and thus may not represent the best approaches to ensuring prolonged survival with preserved quality of life. This review aims to highlight the current literature on surgical and medical management, including our own experience, for GBM in the elderly patients, and to provide rational treatment approaches for a vulnerable, often-overlooked, patient population.
Medical subject headings
- Aging
- Antineoplastic Agents, Alkylating
- Brain Neoplasms
- Glioblastoma